Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 16, 2025 | BridGene Biosciences | $28.0M Series B | Yuexing Su | GTJA Investment Group, Lapam Capital, Proxima Ventures |
| Aug 15, 2015 | Ascentage Pharma | $15.5M Series A | Oriza Ventures, YuanMing Capital | BioVentures Investors, Efung Capital |